Tiny Things with Enormous Impact: Nanotechnology in the Fight Against Infectious Disease
Open accessAbstract
Nanoparticles have exceptional properties that make them outstanding candidates for improving diagnostics and the treatment of infectious disease. Their small size, distinctive intrinsic properties, and ability to be decorated with a variety of complex functionalities make them uniquely capable of detection and targeting of certain diseases. Nanotechnology has the ability to increase the sensitivity of detection methods, the potency and ease of treatment, and the effectiveness of vaccinations. However, major challenges remain to their application in low-resource settings due in large part to the sensitivity of these particles to their local environment, a property that makes them both exceptional for detection and prone to complications or failure during synthesis and utilization. These challenges are likely to be solved only by continued and enhanced communication across scientific disciplines, for example, medical doctors and diagnosticians providing information about what is needed in new technologies. This information will enable materials scientists and engineers to rapidly address the corresponding technical challenges, such as the scalable and reproducible generation of nontoxic and stable, yet responsible nanoparticles.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The synthesis and storage conditions of some nanoparticles may not be conducive to conditions in low-resource countries.
“Second, the synthesis and storage conditions of some nanoparticles may not be conducive to conditions in low-resource countries 141 .”
From Nanotechnology approaches for global infectious diseases (2021) · cites this paper as [141]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Towards a definition of inorganic nanoparticles from an environmental, health and safety perspective
Auffan, M., Rose, J., Bottero, J., Lowry, G. V., Jolivet, J., & Wiesner, M. R. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.242 · Cited by 1,957 · see citing works
Pandey, R., Zahoor, A., Sharma, S., & Khuller, G. K. (2003) · Tuberculosis · doi:10.1016/j.tube.2003.07.001 · Cited by 220 · see citing works
Diagnosis of Tuberculosis Using Colorimetric Gold Nanoparticles on a Paper-Based Analytical Device
Tsai, T., Huang, C.-Y., Chen, C., Shen, S.-W., Wang, M.-C., Chen, C., & Chen, C. (2017) · ACS Sensors · doi:10.1021/acssensors.7b00450 · Cited by 154 · see citing works
Xu, L., Liu, Y., Chen, Z., et al. (2013) · Advanced Materials · doi:10.1002/adma.201300583 · Cited by 141 · see citing works
Advances in biosensors and optical assays for diagnosis and detection of malaria
Ragavan, K. V., Kumar, S., Swaraj, S., & Neethirajan, S. R. (2018) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2018.01.037 · Cited by 127 · see citing works
Paris, L., Magni, R., Zaidi, F., Araujo, R. P., Saini, N., Harpole, M. G., Coronel, J., Kirwan, D. E., Steinberg, H. E., Gilman, R. H., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal2807 · Cited by 123 · see citing works
Isacchi, B., Arrigucci, S., la Marca, G., et al. (2010) · Journal of Liposome Research · doi:10.3109/08982104.2010.539185 · Cited by 102 · see citing works
Urbán, P., Estelrich, J., Cortés, A., & Fernàndez-Busquets, X. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.001 · Cited by 90 · see citing works
Nanomimics of Host Cell Membranes Block Invasion and Expose Invasive Malaria Parasites
Najer, A., Wu, D., Bieri, A., Brand, F., Palivan, C. G., Beck, H., & Meier, W. P. (2014) · ACS Nano · doi:10.1021/nn5054206 · Cited by 69 · see citing works
Jain, P., Chakma, B., Singh, N. K., et al. (2016) · Molecular Biotechnology · doi:10.1007/s12033-016-9946-x · Cited by 42 · see citing works
Chunduri, L. A. A., Kurdekar, A. D., Haleyurgirisetty, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07299-1 · Cited by 34 · see citing works
Choi, S.-R., Britigan, B., & Narayanasamy, P. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02505-16 · Cited by 29 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Nanotechnology approaches for global infectious diseases
Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520 · see citing works
- Authors
- Mitchell, S. L., & Carlson, E. E.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Carlson, Erin E.
- Venue
- ACS Infectious Diseases
- Publisher
- American Chemical Society (ACS)
- Published
- 2018-08-02
- Volume
- 4
- Issue
- 10
- Pages
- 1432-1435
- ISSN
- 2373-8227 (ISSN-L)
- PMC
- PMC9701496
- OpenAlex
- W2885209763
- Cited by
- 23
- References
- 12
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 6 · 2022: 1 · 2021: 5 · 2020: 2 · 2019: 2
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- ACS Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Division of Chemistry (CHE-1503408)
- University of Minnesota
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Biosensors and Analytical Detection
- Physical Sciences › Engineering › Biomedical Engineering › Nanotechnology research and applications
- Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
- Keywords
- nanotechnology, nanoparticles, infectious disease diagnostics, infection treatment, nanoparticle stability, resource-limited settings, vaccine delivery, scalable nanoparticle synthesis, interdisciplinary collaboration
- MeSH terms
- Animals, Communicable Diseases, Enzyme-Linked Immunosorbent Assay, Humans, Patient Compliance, Vaccination, Drug Delivery Systems, Nanotechnology, Mice, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
